BE650350A - COMPOSITION FOR THE TREATMENT OF DROPS - Google Patents

COMPOSITION FOR THE TREATMENT OF DROPS

Info

Publication number
BE650350A
BE650350A BE650350DA BE650350A BE 650350 A BE650350 A BE 650350A BE 650350D A BE650350D A BE 650350DA BE 650350 A BE650350 A BE 650350A
Authority
BE
Belgium
Prior art keywords
drops
treatment
composition
Prior art date
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE650350A publication Critical patent/BE650350A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE650350D 1963-07-15 1964-07-09 COMPOSITION FOR THE TREATMENT OF DROPS BE650350A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29518763A 1963-07-15 1963-07-15

Publications (1)

Publication Number Publication Date
BE650350A true BE650350A (en) 1965-01-11

Family

ID=23136613

Family Applications (1)

Application Number Title Priority Date Filing Date
BE650350D BE650350A (en) 1963-07-15 1964-07-09 COMPOSITION FOR THE TREATMENT OF DROPS

Country Status (5)

Country Link
BE (1) BE650350A (en)
FR (1) FR4143M (en)
GB (1) GB1072771A (en)
IL (1) IL21582A (en)
NL (4) NL6408031A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232785A1 (en) * 2000-01-14 2001-07-24 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
US11116737B1 (en) * 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Also Published As

Publication number Publication date
NL6408031A (en) 1965-01-18
GB1072771A (en) 1967-06-21
FR4143M (en) 1966-05-09
NL7008877A (en) 1970-10-26
NL7008875A (en) 1970-10-26
NL7008876A (en) 1970-10-26
IL21582A (en) 1968-08-22

Similar Documents

Publication Publication Date Title
CH443268A (en) Process for the preparation of new pseudo-ionones
CH550853A (en) COMPOSITION FOR THE TREATMENT OF TEXTILES.
FR1593M (en) Compositions for the treatment of acne.
OA00339A (en) Composition for hair treatment.
BE754628A (en) RETRACTOR FOR THE TREATMENT OF HEMORROIDS
CH427836A (en) Process for the preparation of 2-mercaptoinosine
CH473235A (en) Composition for the treatment of metal surfaces
BE650350A (en) COMPOSITION FOR THE TREATMENT OF DROPS
FR3277M (en) Composition for the treatment of metabolic degenerations.
FR1367854A (en) Composition for the treatment of the hair
FR1372394A (en) Composition of niobium
FR1338926A (en) Furnace for the treatment of strips
FI43878C (en) Process for the preparation of antidiabetically effective 2-benzenesulfonamidopyrimidines
FR1529230A (en) Compositions for the surface treatment of metals
FR1431678A (en) Method for the isolation of alpha1-antitrypsin
FR1378835A (en) Fluid treatment
FR1378045A (en) Modification of polyodefins
FR1502395A (en) Plant for the treatment of textiles
FR2536M (en) New composition for the treatment of bilharzia.
FR1366363A (en) Composition for soil treatment
FR1403710A (en) Process for the preparation of nu-sulfonylamidines
FR1415468A (en) Process for the preparation of tetrahydropyrimidines
FR2685M (en) Detergent composition for the treatment of skin conditions.
FR1494688A (en) Composition for the treatment of plants
FR2524M (en) Stable infusable composition for the treatment of tuberculosis.